EUCTR2004-001457-28-IT进行中（未招募）不适用
Phase II open label study of CT-2106 as a single agent in patients with advanced metastatic ovarian cancer who have failed one prior platinum and taxane based regimen
CELL THERAPEUTICS EUROPE0 个研究点开始时间: 2005年1月3日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
进行中（未招募）
1 期
Phase II open label study of CT-2106 as a single agent in patients with advanced metastatic ovarian cancer who have failed one prior platinum and taxane based regimeAdvanced metastatic ovarian cancerEUCTR2004-001457-28-GBCell Therapeutics Europe S.r.l80
招募中
1 期
A Phase I/II Study of MT-2111 in Patients with Relapsed/Refractory DLBCPatients with relapsed/refractory DLBCJPRN-jRCT2021220031Kazuoki Kondou49
进行中（未招募）
1 期
A Non-Placebo Clinical Trial in Patients with Chronic Liver Disease to Test the Safety and Effect of N-003 on Liver Blood Pressure and Renal Function, as well as N-003 Levels in BloodEUCTR2018-002088-25-ESoorik Biopharmaceuticals AG24
进行中（未招募）
1 期
A Non-Placebo Clinical Trial in Patients with Chronic Liver Disease to Test the Safety and Effect of N-003 on Liver Blood Pressure and Renal Function, as well as N-003 Levels in Blooddecompensated liver cirrhosisMedDRA version: 20.1Level: LLTClassification code 10064704Term: Decompensated cirrhosisSystem Organ Class: 100000004871EUCTR2018-002088-25-AToorik Biopharmaceuticals AG24
进行中（未招募）
1 期
A Phase I/II Open-Label Study of ECT-001-Expanded Cord Blood Transplantation in pediatric and young adult (<21year) Patients with High-Risk and Very High-Risk Myeloid Malignancies (ECT-001-CB.007)High-Risk and Very High-Risk Paediatric Myeloid MalignanciesEUCTR2024-000261-24-Outside-EU/EEACordex Biolohics Inc